Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Ferrol (32)

2021

  1. Variability of blood eosinophil count and prognosis of COPD exacerbations

    Annals of Medicine, Vol. 53, Núm. 1, pp. 1152-1158

2020

  1. Impact of hyponatremia on COPD exacerbation prognosis

    Journal of Clinical Medicine, Vol. 9, Núm. 2

  2. Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 12, pp. 3517-3524

2019

  1. Breastfeeding knowledge and relation to prevalence

    Revista da Escola de Enfermagem, Vol. 53

2018

  1. Alcohol consumption and lung cancer risk in never smokers: A pooled analysis of case-control studies

    European Journal of Public Health, Vol. 28, Núm. 3, pp. 521-527

  2. Infant feeding attitudes and practices of spanish low-risk expectantwomen using the IIFAS (Iowa infant feeding attitude scale)

    Nutrients, Vol. 10, Núm. 4

2017

  1. Discordance of physician clinical judgment vs. pneumonia severity index (PSI) score to admit patients with low risk communityacquired pneumonia: A prospective multicenter study

    Journal of Thoracic Disease, Vol. 9, Núm. 6, pp. 1538-1546

  2. Environmental tobacco smoke exposure and EGFR and ALK alterations in never smokers' lung cancer. Results from the LCRINS study

    Cancer Letters, Vol. 411, pp. 130-135

  3. Simplification to dual therapy (atazanavir/ritonavir1lamivudine) versus standard triple therapy [atazanavir/ritonavir1two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 1, pp. 246-253

2016

  1. Residential radon, EGFR mutations and ALK alterations in never-smoking lung cancer cases

    European Respiratory Journal, Vol. 48, Núm. 5, pp. 1462-1470

  2. Small cell lung cancer in never-smokers

    European Respiratory Journal, Vol. 47, Núm. 3, pp. 947-953

  3. Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients

    Journal of Aerosol Medicine and Pulmonary Drug Delivery, Vol. 29, Núm. 2, pp. 142-152

2015

  1. Alpha-1 Antitrypsin Deficiency and Lung Cancer Risk: A Case-Control Study in Never-Smokers

    Journal of Thoracic Oncology, Vol. 10, Núm. 9, pp. 1279-1284

  2. Cell membrane CD44v6 levels in squamous cell carcinoma of the lung: Association with high cellular proliferation and high concentrations of EGFR and CD44V5

    International Journal of Molecular Sciences, Vol. 16, Núm. 3, pp. 4372-4378

  3. Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

    The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 775-784

  4. Histological grade (HG) in invasive ductal carcinomas of the breast of less than 1 cm: Clinical and biological associations during progression from HG1 to HG3

    Anticancer Research, Vol. 35, Núm. 1, pp. 569-574

  5. Residential radon and lung cancer characteristics in never smokers

    International Journal of Radiation Biology, Vol. 91, Núm. 8, pp. 605-610

2014

  1. Influencia de la edad en la enfermedad neumocócica invasiva y en la resistencia a antimicrobianos

    Medicina Clinica, Vol. 143, Núm. 7, pp. 287-292

  2. Leisure time activities related to carcinogen exposure and lung cancer risk in never smokers. A case-control study

    Environmental Research, Vol. 132, pp. 33-37

  3. Lung cancer in never-smokers: A case-control study in a radon-prone area (Galicia, Spain)

    European Respiratory Journal, Vol. 44, Núm. 4, pp. 994-1001